(Hypertension. 1997;29:1058-1063.)
© 1997 American Heart Association, Inc.
Articles |
Increased Membrane Ratios of Metabolite to Precursor Fatty Acid in Essential Hypertension
From the Institute of Medical Pathology, Chair of Internal Medicine, University of Verona (Italy).
Correspondence to Prof Roberto Corrocher, Institute of Medical Pathology, Chair of Internal Medicine, Policlinico Borgo Roma, 37134 Verona, Italy.
Abstract Desaturase enzymes are responsible for the conversion of essential fatty acids to the longer-chain eicosanoid precursors. These enzymes require zinc as an essential cofactor, and the following ratios—C20:4/C18:2, C20:5/C18:3, and C22:6/C20:5—are considered indexes of their activity. We analyzed these parameters in plasma and erythrocyte membranes of 105 essential hypertensive patients, 20 white coat hypertensive patients, and 100 age-matched normotensive control subjects. Dietary analysis excluded significant quantitative and qualitative differences in fatty acid dietary intake between essential hypertensive patients and normotensive control subjects. Zinc levels and C20:4/C18:2, C20:5/C18:3, and C22:6/C20:5 ratios were significantly higher in essential hypertensive patients than control subjects, whereas white coat hypertensive patients showed intermediate values for all these parameters. These data provide evidence for an alteration in fatty acid metabolism of essential hypertensive patients, consistent with increased activity of desaturase enzymes. The consequent greater bioavailability of eicosanoid precursors, and in particular of arachidonic acid, could affect several vascular functions and have a bearing on the pathogenesis or complications of hypertension.
Key Words: zinc • fatty acids • hypertension, essential • hypertension, white coat • fatty acid desaturases
This article has been cited by other articles:
 |
|
 |
|
  J. Shannon, I. B King, J. W Lampe, D. L. Gao, R. M Ray, M.-G. Lin, H. Stalsberg, and D. B Thomas Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China Am. J. Clinical Nutrition, January 1, 2009; 89(1): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Martinelli, D. Girelli, G. Malerba, P. Guarini, T. Illig, E. Trabetti, M. Sandri, S. Friso, F. Pizzolo, L. Schaeffer, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease Am. J. Clinical Nutrition, October 1, 2008; 88(4): 941 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Bruder, P. C. Lee, and H. Raff Metabolic Consequences of Hypoxia from Birth and Dexamethasone Treatment in the Neonatal Rat: Comprehensive Hepatic Lipid and Fatty Acid Profiling Endocrinology, November 1, 2004; 145(11): 5364 - 5372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Park, Y. Liu-Stratton, L. C. Medeiros, S. A. Mccune, and M. J. Radin Effect of Male Sex and Obesity on Platelet Arachidonic Acid in Spontaneous Hypertensive Heart Failure Rats Experimental Biology and Medicine, July 1, 2004; 229(7): 657 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Alemany, S. Teres, C. Baamonde, M. Benet, O. Vogler, and P. V. Escriba 2-Hydroxyoleic Acid: A New Hypotensive Molecule Hypertension, February 1, 2004; 43(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. Escriba, J. M. Sanchez-Dominguez, R. Alemany, J. S. Perona, and V. Ruiz-Gutierrez Alteration of Lipids, G Proteins, and PKC in Cell Membranes of Elderly Hypertensives Hypertension, January 1, 2003; 41(1): 176 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grimsgaard, K. H. Bonaa, B. K. Jacobsen, and K. S. Bjerve Plasma Saturated and Linoleic Fatty Acids Are Independently Associated With Blood Pressure Hypertension, September 1, 1999; 34(3): 478 - 483. [Abstract] [Full Text] [PDF]
|
|